The mitochondrial permeability transition from in vitro artifact to disease target.

The FEBS Journal
Paolo BernardiMichael A Forte

Abstract

The mitochondrial permeability transition pore is a high conductance channel whose opening leads to an increase of mitochondrial inner membrane permeability to solutes with molecular masses up to approximately 1500 Da. In this review we trace the rise of the permeability transition pore from the status of in vitro artifact to that of effector mechanism of cell death. We then cover recent results based on genetic inactivation of putative permeability transition pore components, and discuss their meaning for our understanding of pore structure. Finally, we discuss evidence indicating that the permeability transition pore plays a role in pathophysiology, with specific emphasis on in vivo models of disease.

References

Jul 1, 1979·Archives of Biochemistry and Biophysics·R A Haworth, D R Hunter
Jul 1, 1979·Archives of Biochemistry and Biophysics·D R Hunter, R A Haworth
Jul 1, 1979·Archives of Biochemistry and Biophysics·D R Hunter, R A Haworth
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M W McEneryS H Snyder
Feb 1, 1992·Journal of Bioenergetics and Biomembranes·I Szabó, M Zoratti
Jun 15, 1992·FEBS Letters·K M BroekemeierD R Pfeiffer
Dec 1, 1991·Journal of Molecular and Cellular Cardiology·W NazarethM Crompton
Sep 16, 1991·Biochemical and Biophysical Research Communications·J M BondJ J Lemasters
May 1, 1990·The American Journal of Physiology·T E Gunter, D R Pfeiffer
Aug 1, 1989·Journal of Bioenergetics and Biomembranes·K W KinnallyH Tedeschi
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A VermaS H Snyder
Oct 1, 1986·The Biochemical Journal·I Al-Nasser, M Crompton
Jun 1, 1987·Journal of Bioenergetics and Biomembranes·N FournierA Crevat
Mar 1, 1988·Biochemical Pharmacology·P M Sokolove, R G Shinaberry
Feb 5, 1973·Biochemical and Biophysical Research Communications·D R Pfeiffer, T T Tchen
Oct 1, 1972·Archives of Biochemistry and Biophysics·A VinogradovB Chance
May 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·G F Azzone, A Azzi
Jul 1, 1984·Archives of Biochemistry and Biophysics·A E Vercesi
Jul 1, 1982·Archives of Biochemistry and Biophysics·K Lê-Quôc, D Lê-Quôc
Oct 1, 1980·Archives of Biochemistry and Biophysics·J L Coelho, A E Vercesi
Dec 1, 1993·Journal of Molecular and Cellular Cardiology·E J Griffiths, A P Halestrap
Oct 1, 1994·Journal of Bioenergetics and Biomembranes·M Zoratti, I Szabó
Feb 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K W KinnallyH Tedeschi

❮ Previous
Next ❯

Citations

Jan 13, 2010·Basic Research in Cardiology·Gerd HeuschRainer Schulz
Mar 16, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Najeeb UllahMyeong Ok Kim
Feb 13, 2007·Apoptosis : an International Journal on Programmed Cell Death·Kathleen W Kinnally, Bruno Antonsson
Feb 13, 2007·Apoptosis : an International Journal on Programmed Cell Death·Andrea Rasola, Paolo Bernardi
Apr 25, 2007·Apoptosis : an International Journal on Programmed Cell Death·Stefan Grimm, Dieter Brdiczka
Dec 17, 2008·Apoptosis : an International Journal on Programmed Cell Death·Gerhard Krumschnabel, Jason E Podrabsky
Jan 1, 2010·Apoptosis : an International Journal on Programmed Cell Death·Michael A MenzeSteven C Hand
Sep 20, 2007·Journal of Inherited Metabolic Disease·S W Sauer
May 23, 2007·Heart Failure Reviews·Fabio Di LisaPaolo Bernardi
May 29, 2007·Heart Failure Reviews·Antonio Rodríguez-SinovasDavid Garcia-Dorado
Jul 26, 2008·Journal of Bioenergetics and Biomembranes·Tatiana K Rostovtseva, Sergey M Bezrukov
Jul 18, 2009·Journal of Bioenergetics and Biomembranes·Mariya V KovalevaRenata A Zvyagilskaya
Aug 21, 2010·Journal of Bioenergetics and Biomembranes·Cecilia ZazuetaEdmundo Chávez
Nov 16, 2011·Journal of Bioenergetics and Biomembranes·Lee J Martin
Jan 17, 2012·Journal of Bioenergetics and Biomembranes·Julie BelliereEric Fontaine
Jul 7, 2011·Pharmaceutical Research·Omar M KhdourSidney M Hecht
Aug 12, 2009·Current Neurology and Neuroscience Reports·Kimmy G SuMichael Forte
Dec 14, 2011·Journal of Molecular Neuroscience : MN·Najeeb UllahMyeong Ok Kim
Sep 7, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·F V DuarteC M Palmeira
Sep 25, 2012·Chemical Research in Toxicology·Katsuhiro OkudaMitsuru Shindo
Dec 28, 2012·Chemical Research in Toxicology·Frederic LamarcheEric Fontaine
Feb 9, 2008·Cell Death and Differentiation·G Loor, P T Schumacker
Apr 10, 2007·Nature Cell Biology·Christopher P BainesJeffery D Molkentin
Oct 9, 2008·Nature Medicine·Anatoly A Starkov, Flint M Beal
Dec 2, 2008·Nature Reviews. Drug Discovery·Inki KimJohn C Reed
Jun 24, 2008·Nature Reviews. Molecular Cell Biology·Yong-Ling P OwTak W Mak
Oct 29, 2008·Oncogene·K W Yip, J C Reed
May 10, 2008·Médecine sciences : M/S·Jean-Claude Kaplan
Jun 2, 2009·Proceedings of the National Academy of Sciences of the United States of America·Ruslan I StanikaS Brian Andrews
Jul 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Alessandro RimessiRosario Rizzuto
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Andrea RasolaPaolo Bernardi
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Valentina GiorgioPaolo Bernardi
Oct 6, 2009·The Journal of Biological Chemistry·Valentina GiorgioGiovanna Lippe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.